chr2-67399586-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_019002.4(ETAA1):c.389G>A(p.Ser130Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,608,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019002.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETAA1 | NM_019002.4 | c.389G>A | p.Ser130Asn | missense_variant | 3/6 | ENST00000272342.6 | NP_061875.2 | |
ETAA1 | XM_017004376.2 | c.389G>A | p.Ser130Asn | missense_variant | 3/7 | XP_016859865.1 | ||
ETAA1 | XM_017004377.2 | c.389G>A | p.Ser130Asn | missense_variant | 3/7 | XP_016859866.1 | ||
ETAA1 | XM_047444809.1 | c.134G>A | p.Ser45Asn | missense_variant | 3/6 | XP_047300765.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETAA1 | ENST00000272342.6 | c.389G>A | p.Ser130Asn | missense_variant | 3/6 | 1 | NM_019002.4 | ENSP00000272342.5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000601 AC: 15AN: 249630Hom.: 0 AF XY: 0.0000667 AC XY: 9AN XY: 134944
GnomAD4 exome AF: 0.000124 AC: 180AN: 1456426Hom.: 0 Cov.: 29 AF XY: 0.000102 AC XY: 74AN XY: 724738
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.389G>A (p.S130N) alteration is located in exon 3 (coding exon 3) of the ETAA1 gene. This alteration results from a G to A substitution at nucleotide position 389, causing the serine (S) at amino acid position 130 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at